ALK y ROS-1 en CNMP: Presente y Futuro - page 28

CRIZOTINIB

Shaw AT, et al. NEJM 2014

ORR=72%

PFS=19.2 m

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,18,19,20,21,22,23,24,25,26,27 29,30,31,32,33